Abstract:*These authors contributed equally to this work Background: Considered as one of the major reasons of sudden cardiac death, hypertrophic cardiomyopathy (HCM) is a common inherited cardiovascular disease. However, effective treatment for HCM is still lacking. Identification of hub gene may be a powerful tool for discovering potential therapeutic targets and candidate biomarkers. Methods: We analysed three gene expression datasets for HCM from the Gene Expression Omnibus. Two of them were merged by “sva” package. The merged dataset was used for analysis while the other dataset was used for validation. Following this, a weighted gene coexpression network analysis (WGCNA) was performed, and the key module most related to HCM was identified. Based on the intramodular connectivity, we identified the potential hub genes. Then, a receiver operating characteristic curve analysis was performed to verify the diagnostic values of hub genes. Finally, we validated changes of hub genes, for genetic transcription and protein expression levels, in datasets of HCM patients and myocardium of transverse aortic constriction (TAC) mice. Results: In the merged dataset, a total of 455 differentially expressed genes (DEGs) were identified from normal and hypertrophic myocardium. In WGCNA, the blue module was identified as the key module and the genes in this module showed a high positive correlation with HCM. Functional enrichment analysis of DEGs and key module revealed that the extracellular matrix, fibrosis, and neurohormone pathways played important roles in HCM. FRZB, COL14A1, CRISPLD1, LUM, and sFRP4 were identified as hub genes in the key module. These genes showed a good predictive value for HCM and were significantly up-regulated in HCM patients and TAC mice. We also found protein expression of LUM and sFRP4 increased in myocardium of TAC mice. Conclusion: This study revealed that five hub genes are involved in the occurrence and development of HCM, and they are potentially to be used as therapeutic targets and biomarkers for HCM.

Genechip-detecting Mutations in Exon 8 in Ctni Gene Associated with FHCM

Applications of Gene-Chip for the Detection of Mutations in Ctni Gene Associated with FHCM

Optimization of Multiplex Pcr Systems for Gene-Chip Detection of Mutations in Exons in Ctni Gene Associated with Fhcm

Characteristics of the beta myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy.

Genetic assay for inherited cardiac arrhythmia

Pgpm_a_314880 823..837

Ile90met, A Novel Mutation In The Cardiac Troponin T Gene For Familial Hypertrophic Cardiomyopathy In A Chinese Pedigree

Positional cloning of disease-causing gene in a Chinese pedigrees with familial hypertrophic cardiomyopathy

Mutation screening of cardiac myosin binding protein-C3 gene in a Chinese pedigree with familial hypertrophic cardiomyopathy

Mutation screening of MYH7 gene in a chinese pedigree with familial hypertrophic cardiomyopathy

Screening pathogenic gene mutation of hypertrophic cardiomyopathy by high throughput sequencing technology

Abstract 11879: the Genetic Characteristics Based on Next Generation Sequencing in Patients with Hypertrophic Cardiomyopathy

Cardiac troponin T2 mutation in 14 cases with familial hypertrophic cardiomyopathy

Exome Sequencing Identifies a Novel MYH7 P.g407c Mutation Responsible for Familial Hypertrophic Cardiomyopathy

Targeted Next-Generation Sequencing Reveals Hot Spots and Doubly Heterozygous Mutations in Chinese Patients with Familial Cardiomyopathy.

Familial Hypertrophic Cardiomyopathy and Troponin T

Gene-echocardiography: Refining Genotype-Phenotype Correlations in Hypertrophic Cardiomyopathy

[Analysis of MYH7, MYBPC3 and TNNT2 Gene Mutations in 10 Chinese Pedigrees with Familial Hypertrophic Cardiomyopathy and the Correlation Between Genotype and Phenotype].

Next-generation sequencing identifies pathogenic and modifier mutations in a consanguineous Chinese family with hypertrophic cardiomyopathy

A novel mutation of the beta myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.

[Comparative Study of Gene Mutation Between Chinese Patients with Familial and Sporadic Hypertrophic Cardiomyopathy].